MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2019 International Congress

    Initial Validation of the Cortical Basal ganglia Functional Scale (CBFS) in two international, multicenter cohorts: 4RTNI and PROSPECT

    A. Boxer, P. Wang, H. Morris, G. Stebbins, A. Lang (Toronto, ON, Canada)

    Objective: To assess the validity of a patient/caregiver-reported scale for assessing functional disability in 4R tauopathies. Background: 4R tauopathies (4RT) including progressive supranuclear palsy (PSP),…
  • 2019 International Congress

    Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

    E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: We aimed to investigate executive functions and languages abilities in PSP patients and in Progressive Supranuclear Palsy (PSP) subgroups [PSP-Richardson’s Syndrome (PSP-RS) and PSP-non-RS]…
  • 2019 International Congress

    Phenotypic spectrum of Progressive Supranuclear Palsy in a Tunisian cohort

    A. Nasri, A. Neji, I. Kacem, T. Lansari, S. Mrabet, A. Gargouri, M. Ben Djebara, R. Gouider (Tunis, Tunisia)

    Objective: To describe the clinical and imaging features of the different phenotypes of progressive supranuclear palsy (PSP). Background: PSP is a neuropathologically defined disease entity…
  • 2019 International Congress

    Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson’s Disease

    E. Fiorenzato, A. Antonini, V. Camparini, L. Weis, C. Semenza, R. Biundo (Venice, Italy)

    Objective: This study investigated neuropsychological tests most sensitive in differentiating progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple system atrophy (MSA), and in…
  • 2019 International Congress

    Quantitative Assessment of Saccadic Eye Movements in Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease

    C. Fearon, Y. Llamas-Osorio, L. Williams, A. Laffan, P. Moloney, R. Field, R. Reilly, T. Lynch (Dublin, Ireland)

    Objective: To investigate whether quantitative assessment of saccadic eye movements can distinguish between patients with progressive supranuclear palsy from patients with idiopathic Parkinson’s disease. Background:…
  • 2019 International Congress

    Differentiation of Progressive Supranuclear Paralysis from Multisystem Atrophy and Parkinson’s Disease by Cranial MRI

    E. Natera-Villalba, V. Ros-Castelló, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, JL. López Sendón, I. Parées-Moreno, JC. Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)

    Objective: To assess differences in cranial MRI between progressive supranuclear palsy (PSP), multisystem atrophy (MSA) and Parkinson's disease (PD) that support the clinical diagnosis. Background:…
  • 2019 International Congress

    Development of a Predictive Model for Progressive Supranuclear Palsy Using Real World Data

    E. Viscidi, Y. Zabar, T. Dam, M. Juneja, J. Kupferman, V. Kupelian, S. Eaton, I. Litvan, G. Hoglinger (Cambridge, MA, USA)

    Objective: To examine diagnoses and symptoms in progressive supranuclear palsy (PSP) patients in the 5 years before PSP diagnosis and to develop a model to…
  • 2019 International Congress

    Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center

    M. Gultekin (Kayseri, Turkey)

    Objective: The purpose of this paper is to emphasize the importance of correct diagnosis in PSP. Background: Progressive supranuclear palsy (PSP) is a commonly disease…
  • 2019 International Congress

    Motor and non-motor symptoms in the prediagnostic phase of progressive supranuclear palsy: the Step-Back PSP study.

    C. Painous, C. Simonet, A. Garrido, N. Caballol, M. Guasp, A. Cámara, F. Valldeoriola, JE. Muñoz, MJ. Martí, Y. Compta (Barcelona, Catalonia)

    Objective: To compare motor and non-motor symptoms in the prediagnostic phase of progressive supranuclear palsy (PSP) with control subjects without neurodegenerative disease (C) as well…
  • 2019 International Congress

    Midbrain Atrophy in Patients with Preclinical Progressive Supranuclear Palsy

    JH. Ahn, M. Kim, J. Youn, JS. Kim, JK. Mun, PH. Lee, SB. Koh, TB. Ahn, JW. Cho (Seoul, Republic of Korea)

    Objective: In the present study, midbrain atrophy and the pons-to-midbrain area ratio (P/M ratio) were investigated as diagnostic markers for preclinical progressive supranuclear palsy (Pre-PSP).…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley